<i>PTEN</i> deletion drives acute myeloid leukemia resistance to MEK inhibitorsAmanda M. Smith(University of Queensland), Andrew S. Moore(University of Queensland)OncotargetOctober 8, 201910.18632/oncotarget.27206Cited by 12SaveCiteExport RISWatch citationsRelated PapersQuizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736|Blood Advances|2020|26